Why the study?
Is glycemic variability associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention?
Is glycemic variability associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention?
Glycemic variability may serve as a marker or risk factor for myocardial damage following PCI in nondiabetic patients presenting with STEMI.
Answers are grounded in this paper and cite their sources.
May flag higher-risk nondiabetic STEMI patients post-PCI; hypothesis-generating and requires prospective validation before clinical use.
GV was associated with myocardial damage after percutaneous coronary intervention in nondiabetic ST-segment elevation myocardial infarction patients.
No takes yet. Share an insight, caveat, or question.
Oka et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: